About this trial
The goal of this open label, randomized, non-inferiority clinical trial is to compare the treatment success of a 5 day antibiotic course versus a standard antibiotic course (usually 7-14 days of antibiotics) in hospitalized children aged 3 months to 18 years, with uncomplicated community acquired pneumonia.
The main questions it aims to answer are:
* Does a 5 day course work as well as standard (longer) courses of antibiotics for treating community acquired pneumonia in children? * Does a 5 day course cause less antibiotic side effects compared to a standard (longer) course of antibiotics in children with community acquired pneumonia?
Participants will
* be randomly assigned to either receive 5 total days or a total duration decided by the treating physician * receive a brief follow up questionnaire regarding clinical symptoms, follow up care/antibiotics, and side effects via phone or email at days 5 and 14 from the start of antibiotics
Researchers will compare the experimental group (receiving 5 days duration) with the control group (standard duration) to see if 5 days is as successful as a standard duration.
Eligibility criteria
Qualifiers
Children aged 3 months to <18 years old
Hospitalized in either the acute care or the pediatric intensive care units
Clinically diagnosed with uncomplicated bacterial community acquired pneumonia (as determined by the treating physician)
Radiological findings suggestive of pneumonia (such as consolidation, lobar or interstitial infiltrates)
Disqualifiers
Hemodynamic instability at any point during hospitalization that required inotropic support
Requirement of respiratory support > 72 hours
Presence of a parapneumonic effusion >10 mm on decubitus x-ray or greater than ¼ of hemithorax opacified on chest imaging
Need for chest tube placement
Trial design
Treatments tested in this trial
- Ampicillin for Injection
- Ceftriaxone for Injection
- Amoxicillin
- Ampicillin / Sulbactam Injection
- Amoxicillin-clavulanate
- Clindamycin
- Cefprozil
- Levofloxacin